{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T09:38:37Z","timestamp":1795081117191,"version":"4.10.2"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T00:00:00Z","timestamp":1625443200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Open Science"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.euros.2021.06.011","type":"journal-article","created":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T06:01:09Z","timestamp":1627020069000},"page":"17-27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"special_numbering":"C","title":["Time to Turn on the Blue Lights: A Systematic Review and Meta-analysis of Photodynamic Diagnosis for Bladder Cancer"],"prefix":"10.1016","volume":"31","author":[{"given":"Rajan","family":"Veeratterapillay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2343-3418","authenticated-orcid":false,"given":"Paul","family":"Gravestock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjun","family":"Nambiar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ameet","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Aboumarzouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavan","family":"Rai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"Vale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Heer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euros.2021.06.011_bib0005","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1007\/s00345-019-02984-4","article-title":"The global burden of urinary bladder cancer: an update","volume":"38","author":"Richters","year":"2020","journal-title":"World J Urol"},{"key":"10.1016\/j.euros.2021.06.011_bib0010","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.eururo.2016.06.020","article-title":"Updated 2016 EAU guidelines on muscle-invasive and metastatic bladder cancer","volume":"71","author":"Alfred Witjes","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2021.06.011_bib0015","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1016\/S0140-6736(16)30512-8","article-title":"Bladder cancer","volume":"388","author":"Kamat","year":"2016","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.euros.2021.06.011_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.eururo.2005.12.031","article-title":"Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials","volume":"49","author":"Sylvester","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2021.06.011_bib0025","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0302-2838(02)00402-5","article-title":"Fluorescence detection of bladder cancer: a review","volume":"42","author":"D\u2019Hallewin","year":"2002","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2021.06.011_bib0030","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1089\/clm.1996.14.289","article-title":"Photodynamic therapy (PDT) and photodiagnosis (PD) using endogenous photosensitization induced by 5-aminolevulinic acid (ALA): mechanisms and clinical results","volume":"14","author":"Kennedy","year":"1996","journal-title":"J Clin Laser Med Surg"},{"key":"10.1016\/j.euros.2021.06.011_bib0035","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.eururo.2007.11.048","article-title":"Photodynamic diagnosis in urology: state-of-the-art","volume":"53","author":"Jocham","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2021.06.011_bib0040","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/01.ju.0000100480.70769.0e","article-title":"Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy","volume":"171","author":"Schmidbauer","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.euros.2021.06.011_bib0045","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.juro.2007.03.028","article-title":"A comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of carcinoma in situ in patients with bladder cancer: a phase III, multicenter study","volume":"178","author":"Fradet","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.euros.2021.06.011_bib0050","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.juro.2007.03.034","article-title":"A phase III, multicenter comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of superficial papillary lesions in patients with bladder cancer","volume":"178","author":"Grossman","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.euros.2021.06.011_bib0055","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/01.ju.0000060782.52358.04","article-title":"Hexyl aminolevulinate fluorescence cystoscopy: new diagnostic tool for photodiagnosis of superficial bladder cancer\u2014a multicenter study","volume":"170","author":"Jichlinski","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.euros.2021.06.011_bib0060","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1017\/S0266462310001364","article-title":"Photodynamic diagnosis of bladder cancer compared with white light cystoscopy: systematic review and meta-analysis","volume":"27","author":"Mowatt","year":"2011","journal-title":"Int J Technol Assess Health Care"},{"key":"10.1016\/j.euros.2021.06.011_bib0065","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.eururo.2013.07.007","article-title":"Hexyl aminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: a critical review of the current literature","volume":"64","author":"Rink","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2021.06.011_bib0070","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0022-5347(05)64833-1","article-title":"Clinically relevant improvement of recurrence-free survival with 5-aminolevulinic acid induced fluorescence diagnosis in patients with superficial bladder tumors","volume":"168","author":"Filbeck","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.euros.2021.06.011_bib0075","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0022-5347(05)66442-7","article-title":"Fluorescence endoscopy with 5-aminolevulinic acid reduces early recurrence rate in superficial bladder cancer","volume":"165","author":"Riedl","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.euros.2021.06.011_bib0080","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/j.juro.2010.06.148","article-title":"Hexaminolevulinate guided fluorescence cystoscopy reduces recurrence in patients with nonmuscle invasive bladder cancer","volume":"184","author":"Stenzl","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.euros.2021.06.011_bib0085","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1111\/bju.12355","volume":"112","author":"O\u2019Brien","year":"2013","journal-title":"BJU Int"},{"issue":"3 Pt 1","key":"10.1016\/j.euros.2021.06.011_bib0090","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.juro.2016.10.061","article-title":"Comparative effectiveness of fluorescent versus white light cystoscopy for initial diagnosis or surveillance of bladder cancer on clinical outcomes: systematic review and meta-analysis","volume":"197","author":"Chou","year":"2017","journal-title":"J Urol"},{"key":"10.1016\/j.euros.2021.06.011_bib0095","series-title":"Cochrane handbook for systematic reviews of interventions","author":"Higgins","year":"2019"},{"key":"10.1016\/j.euros.2021.06.011_bib0100","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ijsu.2010.02.007","article-title":"Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement","volume":"8","author":"Moher","year":"2010","journal-title":"Int J Surg"},{"key":"10.1016\/j.euros.2021.06.011_bib0105","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.euros.2021.06.011_bib0110","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"8 Pt 2","key":"10.1016\/j.euros.2021.06.011_bib0115","first-page":"E297","article-title":"Fluorescence-guided transurethral resection of bladder tumours reduces bladder tumour recurrence due to less residual tumour tissue in Ta\/T1 patients: a randomized two-centre study","volume":"108","author":"Hermann","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.euros.2021.06.011_bib0120","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1464-410X.2011.10374.x","article-title":"Treatment changes and long-term recurrence rates after hexaminolevulinate (HAL) fluorescence cystoscopy: does it really make a difference in patients with non-muscle-invasive bladder cancer (NMIBC)","volume":"109","author":"Geavlete","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.euros.2021.06.011_bib0125","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.urology.2012.03.067","article-title":"Hexaminolevulinate-induced fluorescence versus white light during transurethral resection of noninvasive bladder tumor: does it reduce recurrences","volume":"80","author":"Karaolides","year":"2012","journal-title":"Urology"},{"key":"10.1016\/j.euros.2021.06.011_bib0130","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s11255-013-0603-z","article-title":"Hexaminolevulinate-guided transurethral resection of non-muscle-invasive bladder cancer does not reduce the recurrence rates after a 2-year follow-up: a prospective randomized trial","volume":"46","author":"Gkritsios","year":"2014","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.euros.2021.06.011_bib0135","first-page":"1279","article-title":"Improved diagnosis and long-term recurrence rate reduction for non-muscle-invasive bladder cancer patients undergoing fluorescent hexylaminolevulinate photodynamic diagnosis","volume":"58","author":"Dr\u0103goescu","year":"2017","journal-title":"Rom J Morphol Embryol"},{"key":"10.1016\/j.euros.2021.06.011_bib0140","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/j.1464-410X.2004.05715.x","article-title":"5-Aminolaevulinic acid-induced fluorescence cystoscopy during transurethral resection reduces the risk of recurrence in stage Ta\/T1 bladder cancer","volume":"96","author":"Babjuk","year":"2005","journal-title":"BJU Int"},{"key":"10.1016\/j.euros.2021.06.011_bib0145","doi-asserted-by":"crossref","DOI":"10.1097\/01.ju.0000181814.73466.14","article-title":"Long-term benefit of 5-aminolevulinic acid fluorescence assisted transurethral resection of superficial bladder cancer: 5-year results of a prospective randomized study","volume":"174","author":"Daniltchenko","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.euros.2021.06.011_bib0150","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.eururo.2009.10.030","article-title":"Transurethral resection of non-muscle-invasive bladder transitional cell cancers with or without 5-aminolevulinic acid under visible and fluorescent light: results of a prospective, randomised, multicentre study","volume":"57","author":"Schumacher","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2021.06.011_bib0155","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1002\/cncr.25523","article-title":"Detection and clinical outcome of urinary bladder cancer with 5-aminolevulinic acid-induced fluorescence cystoscopy: a multicenter randomized, double-blind, placebo-controlled trial","volume":"117","author":"Stenzl","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.euros.2021.06.011_bib0160","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s00345-016-1927-y","article-title":"Results of a prospective randomized study assessing the efficacy of fluorescent cystoscopy-assisted transurethral resection and single instillation of doxorubicin in patients with non-muscle-invasive bladder cancer","volume":"35","author":"Rolevich","year":"2017","journal-title":"World J Urol"},{"key":"10.1016\/j.euros.2021.06.011_bib0165","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.euf.2018.11.005","article-title":"Risk stratification tools and prognostic models in non-muscle-invasive bladder cancer: a critical assessment from the European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel","volume":"6","author":"Soukup","year":"2020","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.euros.2021.06.011_bib0170","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.urology.2014.03.006","article-title":"Safety of hexaminolevulinate for blue light cystoscopy in bladder cancer. A combined analysis of the trials used for registration and postmarketing data","volume":"84","author":"Witjes","year":"2014","journal-title":"Urology"},{"key":"10.1016\/j.euros.2021.06.011_bib0175","doi-asserted-by":"crossref","unstructured":"Mowatt G, Zhu S, Kilonzo M, et al. Systematic review of the clinical effectiveness and cost-effectiveness of photodynamic diagnosis and urine biomarkers (FISH, ImmunoCyt, NMP22) and cytology for the detection and follow-up of bladder cancer. 2010. In: NIHR Health Technology Assessment programme: Executive Summaries. Southampton, UK: NIHR Journals Library; 2003. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK56850\/.","DOI":"10.3310\/hta14040"},{"key":"10.1016\/j.euros.2021.06.011_bib0180","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.eururo.2009.11.041","article-title":"Photodynamic diagnosis in non-muscle-invasive bladder cancer: a systematic review and cumulative analysis of prospective studies","volume":"57","author":"Kausch","year":"2010","journal-title":"Eur Urol"},{"issue":"6 Pt B","key":"10.1016\/j.euros.2021.06.011_bib0185","first-page":"E209","article-title":"Effects of fluorescent light-guided transurethral resection on non-muscle-invasive bladder cancer: a systematic review and meta-analysis","volume":"110","author":"Shen","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.euros.2021.06.011_bib0190","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.eururo.2007.01.064","article-title":"Photodynamic diagnostics and noninvasive bladder cancer: is it cost-effective in long-term application? A Germany-based cost analysis","volume":"52","author":"Burger","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2021.06.011_bib0195","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.pdpdt.2008.05.001","article-title":"The economic benefit of photodynamic diagnosis in non-muscle invasive bladder cancer","volume":"5","author":"Dindyal","year":"2008","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"10.1016\/j.euros.2021.06.011_bib0200","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1080\/00365590902808541","article-title":"Fluorescence-guided transurethral resection of bladder cancer using hexaminolevulinate: analysis of health economic impact in Sweden","volume":"43","author":"Malmstr\u00f6m","year":"2009","journal-title":"Scand J Urol Nephrol"},{"key":"10.1016\/j.euros.2021.06.011_bib0205","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1586\/era.13.60","article-title":"Is photodynamic diagnosis ready for introduction in urological clinical practice","volume":"13","author":"Cordeiro","year":"2013","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.euros.2021.06.011_bib0210","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.eururo.2015.05.050","volume":"69","author":"Sylvester","year":"2016","journal-title":"Eur Urol"}],"container-title":["European Urology Open Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666168321001282?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666168321001282?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T20:06:00Z","timestamp":1762977960000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666168321001282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":42,"alternative-id":["S2666168321001282"],"URL":"https:\/\/doi.org\/10.1016\/j.euros.2021.06.011","relation":{},"ISSN":["2666-1683"],"issn-type":[{"value":"2666-1683","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Time to Turn on the Blue Lights: A Systematic Review and Meta-analysis of Photodynamic Diagnosis for Bladder Cancer","name":"articletitle","label":"Article Title"},{"value":"European Urology Open Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euros.2021.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}